SCHEMBL9511151

SCHEMBL9511151

CCCCCCCCCCCCCCOCC(=O)OCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.62
NAAA Q02083 1/20 0.53
DGKA P23743 1/20 0.48
RAD52 P43351 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
EPHX1 P07099 1/20 0.46
MEN1 O00255 1/20 0.45
THRB P10828 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 1/20 0.45
FAAH O00519 1/20 0.44
TSHR P16473 2/20 0.44
PAM P19021 2/20 0.44
HTR2C P28335 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3819694 1.00 CES2 (0.62) CES2NAAADGKARAD52NPSR1
SCHEMBL27658857 1.00 CES2 (0.62) CES2NAAADGKARAD52NPSR1
SCHEMBL3260402 0.98 CES2 (0.59) CES2NAAADGKARAD52NPSR1
SCHEMBL8735350 0.96 CES2 (0.58) CES2NAAADGKARAD52NPSR1
SCHEMBL17947518 0.96 CES2 (0.57) CES2NAAADGKARAD52NPSR1
SCHEMBL21070768 0.94 CES2 (0.52) CES2NAAADGKARAD52NPSR1
SCHEMBL546058 0.92 CES2 (0.50) CES2NAAADGKANPSR1KMT2A
SCHEMBL8988864 0.92 CES2 (0.50) CES2NAAADGKAMEN1THRB
SCHEMBL8511737 0.90 NAAA (0.67) CES2NAAADGKARAD52NPSR1
SCHEMBL6317486 0.90 CES2 (0.48) CES2NAAADGKANPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0345038-B1 Non-beta-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals NORSK HYDRO AS (NO) 1993-11-03 EP claimed
EP-0345038-A2 Non-beta-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals NORSK HYDRO A/S (NO) 1989-12-06 EP claimed
EP-0345038-B1 Non-beta-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals NORSK HYDRO AS (NO) 1993-11-03 EP disclosed
US-5093365-A Non-β-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals NORSK HYDRO A.S. (NO) 1992-03-03 US disclosed
EP-0345038-A2 Non-beta-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals NORSK HYDRO A/S (NO) 1989-12-06 EP disclosed